Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-03-18 ROWLAND LLOYD A General Counsel Sale −10,203 $0.60 $6K 120,594
2024-08-20 ROWLAND LLOYD A General Counsel Exercise or conversion +11,250 134,978
2024-08-20 ROWLAND LLOYD A General Counsel Sale −4,181 $1.23 $5K 130,797
2024-08-20 ROWLAND LLOYD A General Counsel Exercise or conversion · Performance Stock Units (PSUs) −11,250 0
2024-03-19 ROWLAND LLOYD A General Counsel Sale −5,268 $2.09 $11K 117,728
2024-01-18 ROWLAND LLOYD A General Counsel Grant or award +25,000 122,996
2024-01-18 ROWLAND LLOYD A General Counsel Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-01-18 ROWLAND LLOYD A General Counsel Grant or award · Performance Stock Units (PSUs) +75,000 75,000
2023-12-20 ROWLAND LLOYD A General Counsel Sale −4,077 $1.38 $6K 97,996
2023-12-17 ROWLAND LLOYD A General Counsel Exercise or conversion +11,250 102,073
2023-12-17 ROWLAND LLOYD A General Counsel Exercise or conversion · Performance Stock Units (PSUs) −11,250 11,250
2023-09-22 ROWLAND LLOYD A General Counsel Sale −5,486 $1.30 $7K 80,609
2023-09-20 ROWLAND LLOYD A General Counsel Grant or award +15,000 86,095
2023-03-16 ROWLAND LLOYD A General Counsel Sale −2,037 $1.98 $4K 71,095
2023-02-02 ROWLAND LLOYD A General Counsel Grant or award +25,000 73,132
2023-02-02 ROWLAND LLOYD A General Counsel Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-02-02 ROWLAND LLOYD A General Counsel Grant or award · Performance Stock Units (PSUs) +75,000 75,000
2022-08-10 ROWLAND LLOYD A General Counsel Grant or award · Stock Option (Right to Buy) +135,000 135,000
2022-08-10 ROWLAND LLOYD A General Counsel Grant or award · Performance Stock Units (PSUs) +22,500 22,500
2022-07-20 ROWLAND LLOYD A General Counsel Sale −5,602 $1.42 $8K 43,689

Page 1 of 2 · 31 trades